CN102154405A - Preparation method of hyaluronic acid - Google Patents

Preparation method of hyaluronic acid Download PDF

Info

Publication number
CN102154405A
CN102154405A CN2011100062269A CN201110006226A CN102154405A CN 102154405 A CN102154405 A CN 102154405A CN 2011100062269 A CN2011100062269 A CN 2011100062269A CN 201110006226 A CN201110006226 A CN 201110006226A CN 102154405 A CN102154405 A CN 102154405A
Authority
CN
China
Prior art keywords
hyaluronic
hyaluronic acid
phk
synthetic
fermentation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2011100062269A
Other languages
Chinese (zh)
Other versions
CN102154405B (en
Inventor
毛自朝
杨发祥
尚海丽
程倩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fermentation Research Center Yunnan Co Ltd
Original Assignee
Fermentation Research Center Yunnan Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fermentation Research Center Yunnan Co Ltd filed Critical Fermentation Research Center Yunnan Co Ltd
Priority to CN 201110006226 priority Critical patent/CN102154405B/en
Publication of CN102154405A publication Critical patent/CN102154405A/en
Application granted granted Critical
Publication of CN102154405B publication Critical patent/CN102154405B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

The invention provides a preparation method of hyaluronic acid. The method comprises the following steps: transforming a recombinant expression vector into the colibacillus to obtain engineering colibacillus by constructing the recombinant expression vector of which hyaluronic acid synzyme gene Has and uridine diphosphate glucose dehydrogenase gene are jointly expressed in the colibacillus; and fermenting the engineering colibacillus to obtain the hyaluronic acid. After the method is used, the production yield of the hyaluronic acid achieves 2.5g/L. compared with the prior art, the yield of the highest HA (hyaluronic acid) obtained by gram positive chained coccus HA synthetic gene spHas expressed in the colibacillus is approximately improved by 10 times.

Description

A kind of hyaluronic preparation method
Technical field
The present invention relates to the gene engineering technology field of microorganism, specifically is to produce hyaluronic preparation method with the plasmid form or with the engineering colon bacillus that the genome conformity mode makes up.
Background technology
E. coli k12 strain system because of genetic background clearly, have numerous genetic transformation systems efficiently and genomic ease for operation is widely used in the metabolic engineering field, to produce high value added product miscellaneous.Do not find as yet at present that natural coli strain has the hyaluronic ability of production.
(Hyaluronic acid HA) separates obtain a kind of and has the high viscosity glycosaminoglycan hyaluronic acid the earliest from buphthalmos.Hyaluronic acid extensively exists in the humans and animals tissue, and its molecular weight is 5 * 10 4To 8 * 10 6Between the dalton, be by β-1, glucuronic acid and β-1 that the 4-glycosidic link connects; nitrogen ethanoyl glucosamine (the β 1-4 D-Glucuronic acid that the 3-glycosidic link connects; GlcA, β 1-3 D-N-acetylglucosamine, the straight-chain polymer that GlcNAc) alternately is formed by connecting.Studies confirm that this polysaccharide has participated in numerous physiological activities such as mammiferous fertilization, fetal development, revascularization and joint lubrication as structure and signaling molecule; Also playing an important role aspect inflammation and injury repairing, the moisture of keeping skin and the elasticity simultaneously.
Discover that the HA oligonucleotide chain of length-specific is being brought into play important function at aspects such as the unusual reparations of antineoplastic immune.Because hyaluronic acid unique chemical characteristic and physiological function, HA and the oligonucleotide chain that comes from HA are widely used in all many-sides such as ophthalmologic operation, arthritis treatment, antitumor, administering mode, cosmetic industry, only HA in 2008 is as raw material, and the dealing money in the world market is about 1,000,000,000 dollars and the trend that increases is year by year arranged.
Occurring in nature HA extensively exists, as the cell envelope of animal tissues Mammals cause of disease bacterium and the chlorella of viral PBCV-1 dip-dye etc.Present commercial HA mainly from the pathogenic bacteria of animal tissues's (as cockscomb, umbilical cord, buphthalmos, knuckle synovia) and cultivator and higher mammal (as strep, Streptococci) the middle extraction.For the consideration of aspects such as resource limit, cost problem and safety of medicine, above-mentioned production is ideal style absolutely not, and the method for more economic, safe and lasting production HA is done one's utmost to explore by international community.
Molecular biology and development of biology are for the solution of the problems referred to above provides important means.To HA synthesis mechanism in animal and microorganism, the researchs such as clone of the building-up process indispensable gene of many HA all are the means by metabolic engineering, and reconstruction or transformation route of synthesis are produced HA and established solid basis in the host living beings of safety.
Japanese scholar in 2004 Chai paddy grows youth etc.(Chinese patent application number be 200480022328.8) attempts HA synthesizing in plant tissue by express the HA synthetic gene (Has) that obtains from human and paramecium virus (PBCV-1) in transgenic plant.Widner B etc. (Bill Widner et al., Hyaluronic Acid Production in Bacillus subtilis Appl. Environ. Microbiol. 2005,71 (7): 3747 – 3752) successful expression obtains from gram-positive strep in subtilis HA synthetic gene, the engineering genus bacillus is fermented in common triangular flask and obtains 0.5-0.6g/L HA content.
Yet produce hyaluronic acid in plant, because of the conversion difficulty of plant, growth cycle is subject to seasonal restrictions, and many conservative environmentalists oppose transgenic plant, and there is environmentally safe potential hazard etc. in transgenic plant itself and is subjected to application limitations.For subtilis, because of this bacterium has the generation intracellular toxin, the report of various big ring grease classes and lipopeptide antibiotic, and can cause through fermentation, be used for the separation and purification cost up of field of medicaments HA, serial problems such as productive rate reduction.
Many intestinal bacteria that derive from human intestinal are beneficial bacterias of safeguarding intestinal microbial balance and HUMAN HEALTH.In addition e. coli k12 strain cording clearly genetic background, have numerous genetic transformation systems efficiently and genome operability, and be widely used in the biological product of metabolic engineering field with the production high added value.For being that the host carries out the Stephanopoulos G study group that the hyaluronic reported first of engineered production is a Massachusetts Institute Technology with intestinal bacteria.2008 these study group pass through at expression in escherichia coli Gram-positive strep HA synthetic gene SpHasWith brand-new synthetic, optimized codon and be used for escherichia coli expression SeHasGene, this research obtain the HA output of the highest about 0.2g/L.This project intestinal bacteria are difficult to obtain the industrialization utilization because of the HA synthetic yield is low.
Summary of the invention
The purpose of this invention is to provide a kind of hyaluronic preparation method who produces with efficient product hyaluronic acid engineering colon bacillus.Overcome and produce hyaluronic shortage of resources, safety issue and low hyaluronic acid synthetic problem in engineering colon bacillus in the prior art.
The present invention produces hyaluronic acid with the efficient product hyaluronic acid engineering colon bacillus of a kind of expression hyaluronan synthase gene (hyaluronic acid synthase Has) and uridine diphosphoglucose dehydrogenase gene (UDP-glucose Dehydrogenase).
The efficient product hyaluronic acid engineering colon bacillus that contains hyaluronan synthase gene and uridine diphosphoglucose dehydrogenase gene is to make up acquisition by the following method:
(1) carrier of construction expression hyaluronan synthase gene Has specifically is that the Has that PCR clones is connected in the colibacillary expression vector (as pQE80l);
(2) carrier of construction expression uridine diphosphoglucose dehydrogenase gene, the uridine diphosphoglucose dehydrogenase gene that PCR is cloned connects in the colibacillary expression vector (as pQE80l);
(3) structure contains hyaluronan synthase gene Has ,With contain the uridine diphosphoglucose dehydrogenase gene, the recombinant vectors of co expression in intestinal bacteria; The uridine diphosphoglucose dehydrogenase gene expression carrier that contains with structure in (2) is the template of PCR, and amplification contains driven element (as T5) and drives KfiThe PCR product that D expresses, and be connected into the expression hyaluronan synthase gene that makes up in (1) HasExpression vector in and obtain to contain hyaluronan synthase gene HasWith the uridine diphosphoglucose dehydrogenase gene, and can be in intestinal bacteria the recombinant vectors of co expression.
(4) hyaluronan synthase gene will be obtained to contain in (3) HasWith the recombinant vectors of uridine diphosphoglucose dehydrogenase gene, transformed into escherichia coli (as the JM109 bacterial strain) obtains the hyaluronic engineering colon bacillus of efficient product through screening.
The hyaluronic engineering colon bacillus of efficient product that contains hyaluronan synthase gene Has and uridine diphosphoglucose dehydrogenase gene used among the present invention is pHK/JM109, classification called after colon bacillus ( Escherichia coli), preserving number is CGMCC No.3926, China Committee for Culture Collection of Microorganisms common micro-organisms center (the being called for short CGMCC) preservation on June 17th, 2010 in the BeiJing, China city.
Hyaluronan synthase gene described in the hyaluronic engineering colon bacillus CGMCC of the described efficient product NO:3926 HasDerive from Pasteurella multocida ( Pasteurella multocida subsp. Multocida) in hyaluronan synthase gene PmHasDescribed uridine diphosphoglucose dehydrogenase gene derives from GDPG dehydrogenase gene in the intestinal bacteria k5 bacterial strain KfiDDescribed expression vector host strain, e. coli jm109 are purchased the company in Promega.
By coexpression hyaluronan synthase gene and contain the engineering colon bacillus pHK/JM109 of uridine diphosphoglucose dehydrogenase gene, and make it utilize simple carbohydrate (as glucose) to synthesize hyaluronic acid.
Produce hyaluronic output for further improving engineering colon bacillus of the present invention,, add fermentation substrate such as nitrogen acetyl grape amine, citric acid in the substratum and make hyaluronic output obtain a large amount of raisings by changing the aeration condition of fermentation culture.
It is as follows to produce hyaluronic method with engineering colon bacillus pHK/JM109:
(1) shake-flask culture is synthetic
Shake-flask culture is synthetic:
In the 500ml triangular flask, contain 25-50 mM K with cumulative volume 100ml-500ml 2HPO 43H 2O, pH6.5-7.2,2-4mM g/L MgSO47H2O, 20-40 mM/L citric acid, 1-2 mM MnCl 2, 300-400 mM glucose 50-75 mM nitrogen acetylglucosamine adds in the system of 5-10 mM lactose, 10-30 g/L glycerine, 3-5g/L Casamino acid (caseinic acid hydrolyzate) and expresses PmHasWith KfiThe pHK/JM109 of D makes somatic cells concentration reach 4-5%(W/V), fermentation condition is 30-33 ℃, 250 rpm, and as follows with 28% V/V() ammoniacal liquor regulate pH to neutral, the fermentation reaction time is 30-36 hour.
HA content can reach (Fig. 1) about 0.75-1 g/L after measured.Because of the synthetic aerobic of HA and than stable p H, for further improving the output of engineering bacteria, the present invention has carried out fermentor tank HA synthetic and has cultivated.
(2) fermentor cultivation is synthetic:
Receive mycin from (penbritin) Amp50-100ug/ml+Km(card) the LB flat board of 25-100ug/ml provokes 3-5 through the single bacterium colony of the pHK/JM109 of line and incubated overnight, place 100ml TB substratum (Terrific Broth:12 g/L peptone (Tryptone), 24 g/L yeast extracts (Yeast extract), 9.4 g/L K 2HPO 4With 2.2 g/L KH 2PO 4, pH6.8) incubated overnight; This culture is through centrifugal collection thalline, thalline suspends with 20-50ml TB, all change the fermentor tank of 1-5L over to, fermentation tank culture medium is the TB substratum and contains Amp50-100 ug/ml+Kmn25-100 ug/ml, cumulative volume is 600-3000 ml, 37 ℃ of controlled temperature, rotating speed 1200 rpm, feeding flow is the mixed gas (oxygen: air 1:10 v/v) of 60 ml/min, be oxygen: air 1:10 v/v, and, cultivated 4 hours, as culture OD with 8% V/V ammoniacal liquor and 4 mol/L HCl adjusting pH to 6.8-7.2 600Reach at 5 o'clock, adding IPTG makes its final concentration reach 0.5-1 mM, simultaneously temperature of reaction being adjusted to 30-33 ℃ cultivated 2 hours, add 50% W/V glucose and 10% W/V ammonium phosphate pH6.8 this moment, make that glucose and ammonium phosphate content are respectively 50 g/L and 1 g/L in the fermented liquid, cultivate after 10 hours for 30 ℃, adding IPTG, glucose and ammonium phosphate once more makes its concentration be respectively 0.5 mM, 50 g/L and 1 g/L, mixed solution is cultivated after 14-30 hour for 30 ℃ and is finished fermentation, obtains the hyaluronic acid of 2-2.5 g/L concentration.
Carry out the production of HA in fermentor tank, cell concn is greatly improved, OD 600Can reach 25-30, HA content obtains 2-3g/L, has improved synthesis capability greatly, for the condition (see figure 1) has been prepared in large-scale production.
Compared with prior art, the invention has the beneficial effects as follows:
1, engineering colon bacillus of the present invention can produce hyaluronic acid 2g/L~2.5g/L, than in the prior art by expression in escherichia coli Gram-positive strep HA synthetic gene spHas and brand-new synthetic, the hyaluronic acid volume of production of the highest about 0.2g/L that optimized codon and be used for that the seHas gene of escherichia coli expression obtains improves nearly 10 times.)
2, the present invention is used in the hyaluronan synthase gene pmHas of derived from gram-negative bacteria for the first time and contains the uridine diphosphoglucose dehydrogenase gene KfiD expresses in the Gram-negative host and produces hyaluronic acid.
Description of drawings
Fig. 1 is the metamorphosis figure behind the synthetic hyaluronic acid of efficient product hyaluronic acid intestinal bacteria pHK/JM109 of the present invention, wherein: A, C:pQE80l/JM109(control strain) use the observation of simple microscope and environmental scanning electronic microscope (ESEM) respectively; B, D:pHK/JM109 use the observation of simple microscope and environmental scanning electronic microscope (ESEM) respectively; A among the B, b, c, d: after the matter that shows transparency acid was synthetic, it is big that thalline becomes, the situation of mutual sticking connection between two bacterium individualities.
Fig. 2 is of the present invention by HA cumulative change figure in the triangular flask cultivation and fermentation process; Show among the figure that pHK/JM109 produces the hyaluronic acid ability greater than pQHK/JM109, and the empty carrier bacterial strain there is not hyaluronic generation.
Fig. 3 is the Fu Jitu of hyaluronic acid (HA) in supernatant in the bacterial strain pHK/JM109 fermentation purge process of the present invention, A:pHK/JM109, and B: the no hyaluronic acid of contrast (pQE80l/JM109) generates.
Fig. 4 produces best hyaluronic acid engineering strain pHK/JM109 through shake flask fermentation among the present invention, the consumption variation diagram of cell concn, hyaluronic accumulation and substrate after fermentation cylinder for fermentation.Showed cell concentration is greatly improved among the figure, OD 600Can reach 25-30, HA content obtains 2-2.5g/L, has put forward synthesis capability greatly, for condition has been prepared in large-scale production.
Embodiment
Embodiment 1
Hyaluronic shake-flask culture is synthetic among the pHK/JM109:
In the 500ml triangular flask, contain 50 mM K with cumulative volume 100ml 2HPO 43H 2O, (pH7.0) 4mM g/L MgSO47H2O, the 20mM/L citric acid, 1mM MnCl2,300mM glucose 50 mM nitrogen acetylglucosamines (GlcNAc), 10mM lactose, 10g/L glycerine, 5g/LCasamino acid(casamino acids) system in add and express PmHasWith KfiThe pHK/JM109 of D makes somatic cells concentration reach 5%(W/V), fermentation condition is 30 ℃, 250rpm, and use 28%(V/V) ammoniacal liquor regulate pH to neutral, the fermentation reaction time is 36 hours.HA content can reach 0.75-1 g/L left and right sides (see figure 2) after measured.
Embodiment 2
In the 2500l triangular flask, contain 25 mM K with cumulative volume 500ml 2HPO 43H 2O, (pH6.5) 2mM g/L MgSO47H2O, 40mM/L citric acid, 2mM MnCl2,400mM glucose 75 mM nitrogen acetylglucosamines (GlcNAc) add in the system of 5mM lactose, 30g/L glycerine, 3g/L casamino acids (Casamino acid) and express PmHasWith KfiThe pHK/JM109 of D makes somatic cells concentration reach 4%(W/V), fermentation condition is 33 ℃, 250rpm, and use 28%(V/V) ammoniacal liquor regulate pH to neutral, the fermentation reaction time is 30 hours.
HA content can reach about 0.7-8.5 g/L after measured.Because of the synthetic aerobic of HA and than stable p H, for further improving the output of engineering bacteria, the present invention has carried out fermentor tank HA synthetic and has cultivated.
Embodiment 3
Hyaluronic fermentor cultivation is synthetic among the pHK/JM109:
Provoke 3-5 the single bacterium colony of the pHK/JM109 through line and incubated overnight from the LB flat board of Amp100ug/ml+Km100 ug/ml, place 100ml TB substratum (Terrific Broth): 12 g/L tryptones (Tryptone), 24 g/L yeast extracts (Yeast extract), 9.4 g/L K 2HPO 4With 2.2 g/L KH 2PO 4(pH6.8), incubated overnight.This culture is through centrifugal collection thalline, and thalline suspends with 20ml TB, all changes the fermentor tank (Bioreactor, BIOSTAT Bplus Sartoris BBI system Germany product) of 1L over to.Fermentation tank culture medium is that TB contains penbritin (Amp) 100ug/ml+ kantlex (Km) 100 ug/ml, and cumulative volume is 600ml.37 ℃ of controlled temperature, rotating speed 1200rpm feeds flow and is the mixed gas (oxygen: air 1:10 v/v) of 60ml/min, and regulates pH to 6.8 automatically with 28% ammoniacal liquor and 4 mol/L HCl.Cultivated about 4 hours, as culture OD 600Reach at 5 o'clock, adding IPTG makes its final concentration reach 1mM, simultaneously temperature of reaction is adjusted to 30 ℃ and cultivates 2 hours to induce the expression of pmHas and kfiD, add 50%(W/V this moment) glucose and 10%(W/V) ammonium phosphate (pH6.8) makes that glucose and ammonium phosphate content are respectively 50g/L and 1g/L in the fermented liquid, cultivate after 10 hours for 30 ℃, adding IPTG, glucose and ammonium phosphate once more makes its concentration be respectively 0.5mM, 50g/L and 1g/L, mixed solution is cultivated after 14 hours for 30 ℃, finish totally 30 hours fermentation reactions, obtain on average to be about 2-3 g/L HA.
Embodiment 4
Hyaluronic fermentor cultivation is synthetic among the pHK/JM109:
Provoke 3-5 the single bacterium colony of the pHK/JM109 through line and incubated overnight from the LB flat board of Amp50ug/ml+Km25 ug/ml, place 100ml TB substratum (Terrific Broth): 12 g/L tryptones (Tryptone), 24 g/L yeast extracts (Yeast extract), 9.4 g/L K 2HPO 4With 2.2 g/L KH 2PO 4(pH6.8), incubated overnight.This culture is through centrifugal collection thalline, and thalline suspends with 50ml TB, all changes the fermentor tank (Bioreactor, BIOSTAT Bplus Sartoris BBI system Germany product) of 5L over to.Fermentation tank culture medium is that TB contains penbritin (Amp) 50ug/ml+ kantlex (Km) 25 ug/ml, and cumulative volume is 3000ml.37 ℃ of controlled temperature, rotating speed 1200rpm feeds flow and is the mixed gas (oxygen: air 1:10 v/v) of 300ml/min, and regulates pH to 7.2 automatically with 28% ammoniacal liquor and 4 mol/L HCl.Cultivated about 4 hours, as culture OD 600Reach at 5 o'clock, add IPTG and make its final concentration reach 1mM, simultaneously temperature of reaction is adjusted to 33 ℃ and cultivates 2 hours to induce PmHasWith KfiDExpression, add 50%(W/V this moment) glucose and 10%(W/V) ammonium phosphate (pH6.8), make that glucose and ammonium phosphate content are respectively 50g/L and 1g/L in the fermented liquid, cultivate after 10 hours for 30 ℃, adding IPTG, glucose and ammonium phosphate once more makes its concentration be respectively 0.5mM, 50g/L and 1g/L, mixed solution is cultivated after 14 hours for 30 ℃, finishes totally 30 hours fermentation reactions, obtains on average to be about 2-3 g/L HA.
From Fig. 4 as seen, carry out the production of HA in fermentor tank, cell concn is greatly improved, OD 600Can reach 25-30, HA content obtains 2-2.5g/L, has put forward synthesis capability greatly, for condition has been prepared in large-scale production.
Hyaluronic extraction with separate:
The reaction mixture of above-mentioned fermentative production adds the dehydrated alcohol of 1/10 volume, 20% hexadecyl bromination ethamine (Cetyl Trimethyl Ammonium Bromide CTAB) and 2 times of volumes, places 10min behind the mixing.Got precipitation in centrifugal 10 minutes with 14000rpm.(too high because of hyaluronic acid contents sometimes, solution is divided into three layers of (see figure 3), and hyaluronic acid is difficult for precipitation, can suitably dilute initial reaction mixture in this case).Precipitation is used 1 times of volume once more, and the sodium-chlor of 1M suspends at 42 ℃ and extracted about 2 hours, the centrifugal collection supernatant liquor of 12000rpm, and after corresponding precipitation is used the resuspended 10min of the sodium-chlor of 1/10 volume 1M once more, resuspended mixing recentrifuge, supernatant solution abandons precipitation after merging.The supernatant solution that merges adds 2.5 times dehydrated alcohol, and mixing was placed 5 minutes, and centrifuging and taking precipitation, precipitation be with after 70% washing with alcohol, drying or heavily be dissolved in the 1M NaCl solution and be used for HA content and molecular weight determination.
The observation of thalli morphology behind the synthetic hyaluronic acid of pHK/JM109:
In HA synthetic reaction system, get about 2 μ l mixtures, place and allow liquid air-dry on the slide glass, air-dry bacterium is with 5 minutes (polychromatophilia reagent of 0.1% polychromatophilia reagent dyeing, Stains all is the Sigma product, http://www.sigmaaldrich.com) this dye liquor solvent (methane amide: Virahol, v/v7:3) preparation.The unnecessary fuel in dyeing back with distilled water flushing after, directly the micro-sight of 1000X is looked into and is collected pictures with CCD.See the metamorphosis of looking into the synthetic back of hyaluronic acid bacterial cell for further improving resolving power, the pHK/JM109 cell is directly observed with environmental scanning electronic microscope (ESEM) in the reaction system.Found that HA synthetic causes the coli somatic overstriking, terminal color depth, the sticking connection of thalline (Fig. 4).Control cells under ESEM (pBQ/JM109) smoother, HA synthetic cell (pHK/JM109) then surface irregularity (see figure 4) and thalline two ends have tangible material to pile up, and illustrate that cell has synthesized HA, and accumulate on the thalline surface.Color depth from the bacterium two ends that observe, infer that two ends may be the main site (see figure 1)s of the active secretion of thalline HA.
Hyaluronic enzymatic degradation is identified:
For further confirming that the said extracted thing is a hyaluronic acid really, utilize Sigma company from separate the hyaluronic acid streptomycete ( Streptomyces hyalurolyticus) middle purifying, the energy hyaluronic Unidasa of single-minded hydrolysis (Sigma product article No.: H 1136) is hydrolyzed, and carries out Analysis and Identification with the ion-exchange type HPLC of Dai An company (Dionex BioLC).With 250mU enzyme/mgHA ratio, 37 ℃ of hydrolysis totally 10 hours, being hydrolyzed respectively at sampling in 0,2.5,5 and 10 hour, the generation of hyaluronic acid 4 oligosaccharides detects in the mixture.The detailed process that ion-exchange type HPLC analyzes is, the enzymolysis biased sample is through 100 ℃, 5min termination reaction, mixture is centrifugal through 13000rpm, 0.2uM strainer filter after, the last Dionex BioLC (Sunnyvale of system, CA, the U.S.) analyze, this system separates with CarboPac PA20 post, electrochemical detector (Dionex ED50 electrochemical detector) carries out signal monitoring, the concrete ginseng of this detector is set to (waveform:t=0.41 sec, p=-2.00 V; T=0.42 sec, p=-2.00 V; T=0.43 sec, p=0.60 V; T=0.44 sec, p=-0.10 V; T=0.50 sec, p=-0.10 V). use the oligosaccharides of buying from Sigma company in the analytic process, Oligo-HA4, (production number: O9140-5MG) identify (appearance time of Dionex BioLC systems analysis is about 15min) for standard substance.Mobile of chromatography is A solution (the 200 mM NaOH that the degassing is handled, B solution (degassing is handled and contained 200 mM NaOH and 1M NaCl), flow velocity is 0.5 ml/min, A liquid and B liquid are all inflated with rare gas element helium in The whole analytical process, and separately proportionlity changes as follows in the gradient elution process: t=0 min, 5:95 (A liquid: B liquid, down together); T=5 min, 5:95; T=10 min, 20:80; T=20 min, 20:80; T=21 min, 100:0; T=30 min, 100:0; T=35 min, 5:95; T=50 min.As shown in Table 1, institute's extract mass-energy is by single-minded degraded hyaluronic acid, derive from separate the hyaluronic acid streptomycete ( Streptomyces hyalurolyticus) Unidasa degrade.Thereby conclusive evidence pmHas and kfiD efficiently express in intestinal bacteria, make the e. coli jm109 bacterial strain that can not synthesize HA under the natural condition change the synthetic bacterial strain of HA.
Figure 85659DEST_PATH_IMAGE001
The mensuration of hyaluronic acid contents:
Conventional hyaluronic analytical procedure is with people such as Bitter (Bitter T et al, A modified uronic acid carbazole reaction .Anal. Biochem. 1,962 4,330 – 334.) carbazole (carbazole) analytical procedure.Hyaluronic content is by its hydrolysate in this method, glucuronic acid (glucuronic acid), content calculate.Learn from else's experience sample 1 mL of different dilutions of detailed process.In ice-water bath, add the 6 mL vitriol oils, after shaking up, be put in and keep 20 min in 85 ℃ of water-baths, take out to place then and be chilled to room temperature on ice, add 0.2 mL carbazole liquid (50 mg carbazoles are dissolved in 50 mL, 95% ethanol), after placing 100 ℃ of water-baths to keep 10 min, taking-up places and is chilled to room temperature on ice, measures the absorption of 530 nm. and typical curve is made of sigma company glucuronic acid standard model.Above-mentioned conventional determining method is proofreaied and correct by the immune analysis method of hyaluronic acid binding protein.Concrete hyaluronic acid radioimmunoassay kit (the Beijing North biotechnology research institute product that adopts, http://www.bnibt.com,) analyze, this assay kit adopts competition radio immunoassay, promptly HA in standard or the testing sample and 125I-HA common with the hyaluronic acid binding protein (HABP) of limiting the quantity of being at war with property association reaction under suitable condition.Part 125I-HA combines with HABP and forms mixture, and another part is unbound state.125I-HA and HABP bonded ratio depend on the content of non-marked HA in standard or the testing sample, and the content of non-marked HA is high more, and the mixture that 125I-HA and HABP form is few more.HA-HABP mixture and HABP antibody and second antibody form crosslinked polymer precipitation gets off, and measures sedimentary radiocounting.Can obtain typical curve and regression equation through after the data processing, find the HA content of sample from typical curve.After proofreading and correct, begin to carry out routine analysis with carbazole (carbazole) analytical procedure.Analytical results show that the shake flask fermentation hyaluronic acid concentration can reach 05g/L and in fermentor tank or the bio-reactor fermentation can make concentration reach 2.5g/L.
Hyaluronan molecule amount Determination of distribution:
For carrying out the mensuration of HA molecular weight distribution, above-mentioned hyaluronic extraction with separate, be dissolved in the 1M Hyaluronic acid sodium salt, add 1/10 volume 3M acetate and receive (pH5.5), equal-volume phenol: (after (1:1v/v) extracting once, water adds 2.5 times of ethanol sedimentation hyaluronic acids to chloroform, after throw out heavily is dissolved among 0.5M acetate and the 0.3 M Na2SO4, ((ASEC, aqueous size exclusion chromatography) method is measured the molecular weight of HA with the water gel exclusion chromatography.Concrete analysis is to carry out in island crystalline substance (Shimadzu) HPLC system; with Viscotek TSK Viscogel PWXL guard column; G3000, G4000 and G6000 connect altogether as analytical column, with RID-10A RI-detector (refractive Index detector) detection signal.The moving phase of chromatography consists of 0.5M acetate and 0.3 M Na2SO4, it is for want of known that flow velocity is controlled to be 0.6 mL/min. by island brilliant LC-20AD solvent transfer system, the hyaluronic acid standard molecule of different molecular weight, with buying from sigma company, (concrete Dextran is respectively a production number 31389 to the dextran of 40-2000kD, Mw~40,000 (Sigma), production number 31390 Mw~70,000 (Sigma), production number 09184, Mw~100,000 (Fluka) and production number 95771 Mw~2,000,000 (Sigma)) for after standard molecular weight comes the production standard curve, and with the known hyaluronic acid of molecular weight (Select-HA Hyaluronan 150K, mol wt 125-175 kDa, sigma production number S0201-1MG) proofread and correct after, estimate the hyaluronic molecular weight ranges that engineering colon bacillus of the present invention is produced.Analytical results shows that the hyaluronic acid molecular-weight average of engineering colon bacillus production of the present invention is between 130-150kD, but with respect to Sigma company hyaluronic acid, the about 4-4.5 of the hyaluronic molecular distribution scope of engineering colon bacillus synthetic of the present invention (Mw/Mn) sees Table 2 greater than Sigma standard transparent matter acid 2.9().
Figure 65117DEST_PATH_IMAGE002
Remarks: the * commercialization is from HA sigma, Mw: polymeric molecular-weight average (weight average of polymer), Mn: polymeric mean number (number average of polymer), Mw/Mn: the molecular distribution scope of polymer.
More than show, in intestinal bacteria,, on express cell, accumulated HA and caused the change of surface structure by expressing hyaluronic acid synthetase pmHas and guanosine diphosphate(GDP) dehydrogenase gene kfiD; Engineering bacteria fermentation culture in common triangular flask can obtain about 1g/L HA content, with the fermentor cultivation of optimizing, put forward synthesis capability greatly, can obtain 2-2.5g/L HA content, produced the hyaluronic acid ability and obviously be better than the synthetic hyaluronic colibacillus engineering strain of report in the past.
Above-described efficient product hyaluronic acid engineering colon bacillus (pHK/JM109) prepares by the following method:
(1) make up the expression vector pQEpmHas contain hyaluronan synthase gene, with the pcr amplification method clone be derived from Pasteurella multocida ( Pasteurella multocidaSubsp. Multocida) in hyaluronan synthase gene ( PAsteurella mUltocida hYaluronic aCid synthase PmHas), the design of its pcr amplification clone the primer is as follows:
Upstream primer pmHas P1 is 5'-TA GGATCC ATGAACACATTATCACAAGCAAT-3', (SEQ ID No:3 in the sequence table) contains BamH I site GGATCC and initiator codon ATG;
Downstream primer is PmHasP2 is 5'-TA GAGCTC TTASEQ ID No:4 in the TAGAGTTATACTATTAATAAT-3'(sequence table), contain SacI site GAGCTC and terminator codon TAA;
The masterplate of PCR is the genomic dna of Pasteurella multocida strains A TCC 15742, the amplified production warp BamH I and SacBehind the I double digestion, connect into the identical restriction enzyme site among the commercial carrier pQE80L, insert fragment after DNA order-checking conclusive evidence does not have sudden change, with obtaining carrier called after pQEpmHas, gene is PmHas(SEQ ID No:1 in the sequence table)
(2) make up the expression vector pQEkfiD contain the uridine diphosphoglucose dehydrogenase gene, with the pcr amplification method clone be derived from come from intestinal bacteria ( Escherichia coli, E.coli) bacterial strain k5( E. coliK5) GDPG dehydrogenase gene (K in 5Capsule gene D, KfiD), the design of primers of amplification is as follows:
Upstream primer KfiD P1:5'-TGG AGATCT ATGSEQ ID No:5 in the TTCGGAACACTAAAAATAACT G-3'(sequence table), contain Bgl II site AGATCT and initiator codon ATG);
Downstream primer KfiD P2:5'-TT CTCGAG TTASEQ ID No:6 in the GTCACATTTAAA CAAATCGCGAC-3'(sequence table), contain XhoI site CTCGAG and terminator codon TAA;
The masterplate of PCR is the genomic dna of intestinal bacteria bacterium k5 strains A TCC 23500, the also product of purifying that successfully increases, warp BglII and XhoBehind the I double digestion, connect into the commercial carrier pQE80L's of Qiagen company BamH I and SalI site, gained carrier after DNA sequencing analysis conclusive evidence is inserted fragment and is not had sudden change, the carrier called after pQEkfiD that obtains, corresponding gene called after KfiD gene (SEQ ID No:2 in the sequence table);
(3) make up co expression hyaluronan synthase gene and the recombinant vectors that contains the uridine diphosphoglucose dehydrogenase gene in the intestinal bacteria:
According to the DNA sequences Design PCR primer of the pQEkfiD carrier that builds, amplification T5 promoters driven KfiThe fragment T5:kfiD that D expresses, concrete primer sequence design is as follows:
Upstream primer T5kfiD P1:5'-TA GAGCTCCCTTTCGTCTTCAC GSEQ ID No:7 in the TCGAGA-3'(sequence table), this primer contains SacThe I site, GAGCTC, wherein subscript G represents C in the original pQE80L carrier is sported G, to eliminate it XhoThe l site, CTCGAG;
Downstream primer T5kfiD P2:5'-TA CTCGAGSEQ ID No:8 in the TTCTGAGGTCATTACTGGATCT-3'(sequence table), this primer contains XhoI site, CTCGAG;
The masterplate of PCR pQEkfiD carrier, the T5:kfiD amplified production of purifying, at first connect into the pGEM-T-Vector(Promega product, www.promega.com) and transformed into escherichia coli JM109 bacterial strain, obtain intermediate carrier pT-T5KfiD, SEQ ID No:9 in the T5:kfiD(sequence table in this carrier) fragment, after sequencing analysis confirmed that nucleotide sequence does not have sudden change, this inserted T5:kfiD(fragment warp SacI and XhoBehind the I double digestion, connect into expression vector pQEpmHas's SacI and SalI site and obtaining PmHasWith KfiThe recombinant vectors pQHK of D gene coexpression in intestinal bacteria;
(4) structure of pHK
Dna sequence dna (GenBank No. Y14439) design primer according to the Gram-negative bacteria host wide spectrum plasmid pBBR122 of German MoBiTec company:
Upstream primer PBBR P1:5'-TTTGGT GTCGACSEQ ID NO:10 in the CTTGCCAGCCCGTGGATATGTGG-3'(sequence table); Contain SalThe I restriction enzyme site, GTCGAC
Downstream primer PBBR P1:5'-TTAGGT GTCGACSEQ ID NO:11 in the TCTGTGATGGCTTCCATGTCGGCAG-3'(sequence table), contain SalThe I restriction enzyme site, GTCGAC);
With comprising its replication site and kalamycin resistance gene among the above-mentioned primer amplification plasmid pBBR122 in interior fragment, the parameter of PCR amplification is: 95 ℃, 2 min, 1 circulation; 94 ℃, 30s, 55 ℃, 30s, 72 ℃, 3 min, 25 circulations; 72 ℃, 1 circulation of 10 min, the about 3.2 kb amplified productions of purifying are used SalBehind the I enzymolysis, add ligase enzyme and connect certainly, self connect product transformed into escherichia coli JM109 bacterial strain by it, and obtain plasmid pRP (SEQ ID NO:12 in the sequence table) with kantlex screening, extract plasmid pRP, behind the SalI enzymolysis, connect into above-mentioned can be in intestinal bacteria coexpression pmHas and KfiThe pQHK's of D gene XhoThe I site, and obtain coexpression in Gram-negative bacteria PmHasWith KfiD synthesizes hyaluronic expression vector pHK;
(5) this recombinant vectors pHK is changed over to the hyaluronic engineering colon bacillus pHK/JM109(CGMCC of the described efficient product of acquisition NO:3926 in the e. coli jm109).
Above-described coli strain pHK/JM109 is the efficient hyaluronic acid engineering colon bacillus that produces, and wherein pHK is an expression vector, and its host strain is E.coliJM109.
Dna sequence dna explanation involved in the present invention:
In the sequence table shown in the SEQ ID NO:1 be derived from Pasteurella multocida ( Pasteurella multocidaSubsp. MultocidaIn hyaluronan synthase gene PmHasThe coding region nucleotide sequence.
In the sequence table shown in the SEQ ID NO:2 is to be derived from intestinal bacteria k5 bacterial strain (middle GDPG dehydrogenase gene KfiDThe coding region nucleotide sequence.
In the sequence table shown in the SEQ ID NO:3 be clone be derived from Pasteurella multocida ( Pasteurella multocidaSubsp. Multocida) in hyaluronan synthase gene PmHasThe base sequence of upstream primer.
In the sequence table shown in the SEQ ID NO:4 be clone be derived from Pasteurella multocida ( Pasteurella multocidaSubsp. Multocida) in hyaluronan synthase gene PmHasThe base sequence of downstream primer.
In the sequence table shown in the SEQ ID NO:5 is that the clone comes from GDPG dehydrogenase gene in the intestinal bacteria k5 bacterial strain KfiThe base sequence of the upstream primer of D.
In the sequence table shown in the SEQ ID NO:6 is that the clone comes from GDPG dehydrogenase gene in the intestinal bacteria k5 bacterial strain KfiThe base sequence of the downstream primer of D.
In the sequence table shown in the SEQ ID NO:7 is the base sequence of the segmental upstream primer of clone T5:kfiD.
In the sequence table shown in the SEQ ID NO:8 is the base sequence of the segmental downstream primer of clone T5:kfiD.
In the sequence table shown in the SEQ ID NO:9 is the segmental nucleotide sequence of T5:kfiD.
In the sequence table shown in the SEQ ID NO:10 is clone's PBRR122 kalamycin resistance gene and the base sequence that duplicates essential segmental upstream primer.
In the sequence table shown in the SEQ ID NO:11 is clone's PBRR122 kalamycin resistance gene and the base sequence that duplicates essential segmental downstream primer.
In the sequence table shown in the SEQ ID NO:12 is the nucleotide sequence of plasmid pRP.
The genetic resources that the present invention relates to:
1: kill Bath DS strains A TCC15742(Pasteurella multocida subsp. multocida (Lehmann and Neumann) Rosenbusch and Merchant) more; Genetic resources is taken from: U.S.'s typical case's culture is preserved center (ATCC); Obtain manner: buy price 225 U.S. dollars; Acquisition time: in January, 2008; Primary source: U.S. scientist KL Heddleston separates acquisition time from the turkey heart: in April, 1962
2: intestinal bacteria K5 strains A TCC23500( Escherichia coli(Migula) Castellani and Chalmers, serotype O2a, 2b:K5 (L): H4; Genetic resources is taken from: U.S.'s typical case's culture is preserved center (ATCC) obtain manner: buy, price 225 U.S. dollars, acquisition time: in September, 2008 primary source: the Center for Disease Control (CDC) scientist Kauffmann separates from people urine, and acquisition time: July nineteen forty-three.
Sequence table
SEQUENCE LISTING
<110〉Yunnan Province's microbial fermentation engineering research centre company limited
<120〉efficiently produce the hyaluronic acid engineering colon bacillus
<130> /
<160> 12
<170> PatentIn version 3.3
<210> 1
<211> 2919
<212> DNA
<213> Pasteurella multocida subsp. Multocida(ATCC15742)
<400> 1
atgaatacat tatcacaagc aataaaagca tataacagca atgactatca attagcactc 60
aaattatttg aaaagtcggc ggaaatctat ggacggaaaa ttgttgaatt tcaaattacc 120
aaatgcaaag aaaaactctc agcacatcct tctgttaatt cagcacatct ttctgtaaat 180
aaagaagaaa aagtcaatgt ttgcgatagt ccgttagata ttgcaacaca actgttactt 240
tccaacgtaa aaaaattagt actttctgac tcggaaaaaa acacgttaaa aaataaatgg 300
aaattgctca ctgagaagaa atctgaaaat gcggaggtaa gagcggtcgc ccttgtacca 360
aaagattttc ccaaagatct ggttttagcg cctttacctg atcatgttaa tgattttaca 420
tggtacaaaa agcgaaagaa aagacttggc ataaaacctg aacatcaaca tgttggtctt 480
tctattatcg ttacaacatt caatcgacca gcaattttat cgattacatt agcctgttta 540
gtaaaccaaa aaacacatta cccgtttgaa gttatcgtga cagatgatgg tagtcaggaa 600
gatctatcac cgatcattcg ccaatatgaa aataaattgg atattcgcta cgtcagacaa 660
aaagataacg gttttcaagc cagtgccgct cggaatatgg gattacgctt agcaaaatat 720
gactttattg gcttactcga ctgtgatatg gcgccaaatc cattatgggt tcattcttat 780
gttgcagagc tattagaaga tgatgattta acaatcattg gtccaagaaa atacatcgat 840
acacaacata ttgacccaaa agacttctta aataacgcga gtttgcttga atcattacca 900
gaagtgaaaa ccaataatag tgttgccgca aaaggggaag gaacagtttc tctggattgg 960
cgcttagaac aattcgaaaa aacagaaaat ctccgcttat ccgattcgcc tttccgtttt 1020
tttgcggcgg gtaatgttgc tttcgctaaa aaatggctaa ataaatccgg tttctttgat 1080
gaggaattta atcactgggg tggagaagat gtggaatttg gatatcgctt attccgttac 1140
ggtagtttct ttaaaactat tgatggcatt atggcctacc atcaagagcc accaggtaaa 1200
gaaaatgaaa ccgatcgtga agcgggaaaa aatattacgc tcgatattat gagagaaaag 1260
gtcccttata tctatagaaa acttttacca atagaagatt cgcatatcaa tagagtacct 1320
ttagtttcaa tttatatccc agcttataac tgtgcaaact atattcaacg ttgcgtagat 1380
agtgcactga atcagactgt tgttgatctc gaggtttgta tttgtaacga tggttcaaca 1440
gataatacct tagaagtgat caataagctt tatggtaata atcctagggt acgcatcatg 1500
tctaaaccaa atggcggaat agcctcagca tcaaatgcag ccgtttcttt tgctaaaggt 1560
tattacattg ggcagttaga ttcagatgat tatcttgagc ctgatgcagt tgaactgtgt 1620
ttaaaagaat ttttaaaaga taaaacgcta gcttgtgttt ataccactaa tagaaacgtc 1680
aatccggatg gtagcttaat cgctaatggt tacaattggc cagaattttc acgagaaaaa 1740
ctcacaacgg ctatgattgc tcaccacttt agaatgttca cgattagagc ttggcattta 1800
actgatggat tcaatgaaaa aattgaaaat gccgtagact atgacatgtt cctcaaactc 1860
agtgaagttg gaaaatttaa acatcttaat aaaatctgct ataaccgtgt attacatggt 1920
gataacacat caattaagaa acttggcatt caaaagaaaa accattttgt tgtagtcaat 1980
cagtcattaa atagacaagg cataacttat tataattatg acgaatttga tgatttagat 2040
gaaagtagaa agtatatttt caataaaacc gctgaatatc aagaagagat tgatatctta 2100
aaagatatta aaatcatcca gaataaagat gccaaaatcg cagtcagtat tttttatccc 2160
aatacattaa acggcttagt gaaaaaacta aacaatatta ttgaatataa taaaaatata 2220
ttcgttattg ttctacatgt tgataagaat catcttacac cagatatcaa aaaagaaata 2280
ctagccttct atcataaaca tcaagtgaat attttactaa ataatgatat ctcatattac 2340
acgagtaata gattaataaa aactgaggcg catttaagta atattaataa attaagtcag 2400
ttaaatctaa attgtgaata catcattttt gataatcatg acagcctatt cgttaaaaat 2460
gacagctatg cttatatgaa aaaatatgat gtcggcatga atttctcagc attaacacat 2520
gattggatcg agaaaatcaa tgcgcatcca ccatttaaaa agctcattaa aacttatttt 2580
aatgacaatg acttaaaaag tatgaatgtg aaaggggcat cacaaggtat gtttatgacg 2640
tatgcgctag cgcatgagct tctgacgatt attaaagaag tcatcacatc ttgccagtca 2700
attgatagtg tgccagaata taacactgag gatatttggt tccaatttgc acttttaatc 2760
ttagaaaaga aaaccggcca tgtatttaat aaaacatcga ccctgactta tatgccttgg 2820
gaacgaaaat tacaatggac aaatgaacaa attgaaagtg caaaaagagg agaaaatata 2880
cctgttaaca agttcattat taatagtata actctataa 2919
<210> 2
<211> 1179
<212> DNA
<213> Escherichia coli K5(ATCC23500)
<400> 2
atgttcggaa cactaaaaat aactgtttca ggcgctggtt acgttgggct ttcaaatgga 60
attctaatgg ctcaaaatca tgaagtggtt gcatttgata cccatcaaaa aaaagttgac 120
ttacttaatg ataaactctc tcctatagag gataaggaaa ttgaaaatta tctttcaact 180
aaaatactta attttcgcgc aactactaac aaatatgaag cctataaaaa tgccaattac 240
gttattattg ctacaccaac gaattatgac ccaggttcaa attactttga tacatcaagc 300
gttgaagctg tcattcgtga cgtaacggaa atcaacccaa acgcaattat ggtggttaaa 360
tctacggtcc cagtaggttt cacaaaaaca attaaagaac atttaggtat taataatatt 420
atcttctctc cagaattttt acgagaagga agagccctat acgataatct ccatccatct 480
cgcattatta tcggtgaatg ttctgaacgg gcagaacgtt tggcagtgtt atttcaggaa 540
ggagcgatta aacaaaatat acccgtttta tttacagatt ctacggaagc ggaagcgatt 600
aagttatttt caaatactta tttggctatg cgagttgcat tttttaatga attggatagt 660
tacgcagaaa gttttggtct gaatacgcgt cagattattg acggtgtttg tttggatccg 720
cgcattggta attactacaa taatccttct tttggttatg gtggctactg tttgccaaaa 780
gataccaagc aattattagc caactatcag tctgttccga ataaacttat atctgcaatt 840
gttgatgcta accgtacacg taaggacttt atcactaatg ttattttgaa acatagacca 900
caagttgtgg gggtttatcg tttgattatg aaaagtggtt cagataattt tagagattct 960
tctattcttg gtattataaa gcgtatcaag aaaaaaggcg tgaaagtaat tatttatgag 1020
ccgcttattt ctggagatac attctttaac tcacctttgg aacgggagct ggcgatcttt 1080
aaagggaaag ctgatattat tatcactaac cgaatgtcag aggagttgaa cgatgtggtc 1140
gacaaagtct atagtcgcga tttgtttaaa tgtgactaa 1179
<210> 3
<211> 31
<212> DNA
<213〉artificial-synthetic DNA
<400> 3
taggatccat gaacacatta tcacaagcaa t 31
<210> 4
<211> 32
<212> DNA
<213〉artificial-synthetic DNA
<400> 4
tagagctctt atagagttat actattaata at 32
<210> 5
<211> 34
<212> DNA
<213〉artificial-synthetic DNA
<400> 5
tggagatcta tgttcggaac actaaaaata actg 34
<210> 6
<211> 34
<212> DNA
<213〉artificial-synthetic DNA
<400> 6
ttctcgagtt agtcacattt aaacaaatcg cgac 34
<210> 7
<211> 29
<212> DNA
<213〉artificial-synthetic DNA
<400> 7
tagagctccc tttcgtcttc acgtcgaga 29
<210> 8
<211> 30
<212> DNA
<213〉artificial-synthetic DNA
<400> 8
tactcgagtt ctgaggtcat tactggatct 30
<210> 9
<211> 1423
<212> DNA
<213〉engineering makes up fragment
<400> 9
tagagctccc tttcgtcttc acgtcgagaa atcataaaaa atttatttgc tttgtgagcg 60
gataacaatt ataatagatt caattgtgag cggataacaa tttcacacag aattcattaa 120
agaggagaaa ttaactatga gaggatcgca tcaccatcac catcacggat ctatgttcgg 180
aacactaaaa ataactgttt caggcgctgg ttacgttggg ctttcaaatg gaattctaat 240
ggctcaaaat catgaagtgg ttgcatttga tacccatcaa aaaaaagttg acttacttaa 300
tgataaactc tctcctatag aggataagga aattgaaaat tatctttcaa ctaaaatact 360
taattttcgc gcaactacta acaaatatga agcctataaa aatgccaatt acgttattat 420
tgctacacca acgaattatg acccaggttc aaattacttt gatacatcaa gcgttgaagc 480
tgtcattcgt gacgtaacgg aaatcaaccc aaacgcaatt atggtggtta aatctacggt 540
cccagtaggt ttcacaaaaa caattaaaga acatttaggt attaataata ttatcttctc 600
tccagaattt ttacgagaag gaagagccct atacgataat ctccatccat ctcgcattat 660
tatcggtgaa tgttctgaac gggcagaacg tttggcagtg ttatttcagg aaggagcgat 720
taaacaaaat atacccgttt tatttacaga ttctacggaa gcggaagcga ttaagttatt 780
ttcaaatact tatttggcta tgcgagttgc attttttaat gaattggata gttacgcaga 840
aagttttggt ctgaatacgc gtcagattat tgacggtgtt tgtttggatc cgcgcattgg 900
taattactac aataatcctt cttttggtta tggtggctac tgtttgccaa aagataccaa 960
gcaattatta gccaactatc agtctgttcc gaataaactt atatctgcaa ttgttgatgc 1020
taaccgtaca cgtaaggact ttatcactaa tgttattttg aaacatagac cacaagttgt 1080
gggggtttat cgtttgatta tgaaaagtgg ttcagataat tttagagatt cttctattct 1140
tggtattata aagcgtatca agaaaaaagg cgtgaaagta attatttatg agccgcttat 1200
ttctggagat acattcttta actcaccttt ggaacgggag ctggcgatct ttaaagggaa 1260
agctgatatt attatcacta accgaatgtc agaggagttg aacgatgtgg tcgacaaagt 1320
ctatagtcgc gatttgttta aatgtgacta actcgaccca agcttaatta gctgagcttg 1380
gactcctgtt gatagatcca gtaatgacct cagaactcga gta 1423
<210> 10
<211> 33
<212> DNA
<213〉artificial-synthetic DNA
<400> 10
tggtgtcgac cttgccagcc cgtggatatg tgg 33
<210> 11
<211> 35
<212> DNA
<213〉artificial-synthetic DNA
<400> 11
aggtgtcgac tctgtgatgg cttccatgtc ggcag 35
<210> 12
<211> 3266
<212> DNA
<213> pBBR122
<400> 12
gtcgaccttg ccagcccgtg gatatgtgga cgatggccgc gagcggccac cggctggctc 60
gcttcgctcg gcccgtggac aaccctgctg gacaagctga tggacaggct gcgcctgccc 120
acgagcttga ccacagggat tgcccaccgg ctacccagcc ttcgaccaca tacccaccgg 180
ctccaactgc gcggcctgcg gccttgcccc atcaattttt ttaattttct ctggggaaaa 240
gcctccggcc tgcggcctgc gcgcttcgct tgccggttgg acaccaagtg gaaggcgggt 300
caaggctcgc gcagcgaccg cgcagcggct tggccttgac gcgcctggaa cgacccaagc 360
ctatgcgagt gggggcagtc gaaggcgaag cccgcccgcc tgccccccga gacctgcagg 420
gggggggggg cgctgaggtc tgcctcgtga agaaggtgtt gctgactcat accaggcctg 480
aatcgcccca tcatccagcc agaaagtgag ggagccacgg ttgatgagag ctttgttgta 540
ggtggaccag ttggtgattt tgaacttttg ctttgccacg gaacggtctg cgttgtcggg 600
aagatgcgtg atctgatcct tcaactcagc aaaagttcga tttattcaac aaagccgccg 660
tcccgtcaag tcagcgtaat gctctgccag tgttacaacc aattaaccaa ttctgattag 720
aaaaactcat cgagcatcaa atgaaactgc aatttattca tatcaggatt atcaatacca 780
tatttttgaa aaagccgttt ctgtaatgaa ggagaaaact caccgaggca gttccatagg 840
atggcaagat cctggtatcg gtctgcgatt ccgactcgtc caacatcaat acaacctatt 900
aatttcccct cgtcaaaaat aaggttatca agtgagaaat caccatgagt gacgactgaa 960
tccggtgaga atggcaaaag cttatgcatt tctttccaga cttgttcaac aggccagcca 1020
ttacgctcgt catcaaaatc actcgcatca accaaaccgt tattcattcg tgattgcgcc 1080
tgagcgagac gaaatacgcg atcgctgtta aaaggacaat tacaaacagg aatcgaatgc 1140
aaccggcgca ggaacactgc cagcgcatca acaatatttt cacctgaatc aggatattct 1200
tctaatacct ggaatgctgt tttcccgggg atcgcagtgg tgagtaacca tgcatcatca 1260
ggagtacgga taaaatgctt gatggtcgga agaggcataa attccgtcag ccagtttagt 1320
ctgaccatct catctgtaac atcattggca acgctacctt tgccatgttt cagaaacaac 1380
tctggcgcat cgggcttccc atacaatcga tagattgtcg cacctgattg cccgacatta 1440
tcgcgagccc atttataccc atataaatca gcatccatgt tggaatttaa tcgcggcctc 1500
gagcaagacg tttcccgttg aatatggctc ataacacccc ttgtattact gtttatgtaa 1560
gcagacagtt ttattgttca tgatgatata tttttatctt gtgcaatgta acatcagaga 1620
ttttgagaca caacgtggct ttcccccccc cccctgcagg tcccgagcct cacggcggcg 1680
agtgcggggg ttccaagggg gcagcgccac cttgggcaag gccgaaggcc gcgcagtcga 1740
tcaacaagcc ccggaggggc cactttttgc cggaggggga gccgcgccga aggcgtgggg 1800
gaaccccgca ggggtgccct tctttgggca ccaaagaact agatataggg cgaaatgcga 1860
aagacttaaa aatcaacaac ttaaaaaagg ggggtacgca acagctcatt gcggcacccc 1920
ccgcaatagc tcattgcgta ggttaaagaa aatctgtaat tgactgccac ttttacgcaa 1980
cgcataattg ttgtcgcgct gccgaaaagt tgcagctgat tgcgcatggt gccgcaaccg 2040
tgcggcaccc taccgcatgg agataagcat ggccacgcag tccagagaaa tcggcattca 2100
agccaagaac aagcccggtc actgggtgca aacggaacgc aaagcgcatg aggcgtgggc 2160
cgggcttatt gcgaggaaac ccacggcggc aatgctgctg catcacctcg tggcgcagat 2220
gggccaccag aacgccgtgg tggtcagcca gaagacactt tccaagctca tcggacgttc 2280
tttgcggacg gtccaatacg cagtcaagga cttggtggcc gagcgctgga tctccgtcgt 2340
gaagctcaac ggccccggca ccgtgtcggc ctacgtggtc aatgaccgcg tggcgtgggg 2400
ccagccccgc gaccagttgc gcctgtcggt gttcagtgcc gccgtggtgg ttgatcacga 2460
cgaccaggac gaatcgctgt tggggcatgg cgacctgcgc cgcatcccga ccctgtatcc 2520
gggcgagcag caactaccga ccggccccgg cgaggagccg cccagccagc ccggcattcc 2580
gggcatggaa ccagacctgc cagccttgac cgaaacggag gaatgggaac ggcgcgggca 2640
gcagcgcctg ccgatgcccg atgagccgtg ttttctggac gatggcgagc cgttggagcc 2700
gccgacacgg gtcacgctgc cgcgccggta gcacttgggt tgcgcagcaa cccgtaagtg 2760
cgctgttcca gactatcggc tgtagccgcc tcgccgccct ataccttgtc tgcctccccg 2820
cgttgcgtcg cggtgcatgg agccgggcca cctcgacctg aatggaagcc ggcggcacct 2880
cgctaacgga ttcaccgttt ttatcaggct ctgggaggca gaataaatga tcatatcgtc 2940
aattattacc tccacgggga gagcctgagc aaactggcct caggcatttg agaagcacac 3000
ggtcacactg cttccggtag tcaataaacc ggtaaaccag caatagacat aagcggctat 3060
ttaacgaccc tgccctgaac cgacgaccgg gtcgaatttg ctttcgaatt tctgccattc 3120
atccgcttat tatacttatt caggcgtagc accaggcgtt taagggcacc aataactgcc 3180
ttaaaaaaat tacgccccgc cctgccactc atcgcagtac tgttgtaatt cattaagcat 3240
tctgccgaca tggaagccat cacaga 3266

Claims (2)

1. hyaluronic preparation method is characterized in that producing with engineering colon bacillus pHK/JM109 that hyaluronic shake-flask culture is synthetic to be undertaken by following: in the 500ml-2500ml triangular flask, contain 25-50 mM K with cumulative volume 100ml-500ml 2HPO 43H 2O, pH6.5-7.2,2-4mM g/L MgSO47H2O, 20-40 mM/L citric acid, 1-2 mM MnCl 2, 300-400 mM glucose 50-75 mM nitrogen acetylglucosamine adds in the system of 5-10 mM lactose, 10-30 g/L glycerine, 3-5g/L caseinic acid hydrolyzate (Casamino acid) and expresses PmHasWith KfiThe pHK/JM109 of D makes somatic cells concentration reach 4-5% W/V, and fermentation condition is 30-33 ℃, 250 rpm, and it is extremely neutral to regulate pH with the ammoniacal liquor of 28% V/V, the fermentation reaction time is 30-36 hour.
2. hyaluronic preparation method, it is characterized in that producing that hyaluronic fermentor cultivation is synthetic is undertaken by following: provoke 3-5 through the single bacterium colony of the pHK/JM109 of line and incubated overnight from the LB flat board of Amp50-100ug/ml+Km25-100ug/ml with engineering colon bacillus pHK/JM109, place 100ml TB substratum (Terrific Broth), incubated overnight; This culture is through centrifugal collection thalline, thalline suspends with 20-50ml TB, all changes the fermentor tank of 1-5L over to, and fermentation tank culture medium is the TB substratum and contains Amp50-100 ug/ml+Kmn25-100 ug/ml, cumulative volume is 600-3000 ml, 37 ℃ of controlled temperature, rotating speed 1200 rpm, feeding flow is the mixed gas of 60 ml/min, be oxygen: air 1:10 v/v, and, cultivated 4 hours, as culture OD with 28% V/V ammoniacal liquor and 4 mol/L HCl adjusting pH to 6.8-7.2 600Reach at 5 o'clock, adding IPTG makes its final concentration reach 0.5-1 mM, simultaneously temperature of reaction being adjusted to 30-33 ℃ cultivated 2 hours, add 50% W/V glucose and 10% W/V ammonium phosphate pH6.8 this moment, make that glucose and ammonium phosphate content are respectively 50 g/L and 1 g/L in the fermented liquid, cultivate after 10 hours for 30 ℃, adding IPTG, glucose and ammonium phosphate once more makes its concentration be respectively 0.5 mM, 50 g/L and 1 g/L, mixed solution is cultivated after 14-30 hour for 30 ℃ and is finished fermentation, obtains the hyaluronic acid of 2-3 g/L concentration.
CN 201110006226 2011-01-13 2011-01-13 Preparation method of hyaluronic acid Active CN102154405B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201110006226 CN102154405B (en) 2011-01-13 2011-01-13 Preparation method of hyaluronic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201110006226 CN102154405B (en) 2011-01-13 2011-01-13 Preparation method of hyaluronic acid

Publications (2)

Publication Number Publication Date
CN102154405A true CN102154405A (en) 2011-08-17
CN102154405B CN102154405B (en) 2013-03-20

Family

ID=44436076

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201110006226 Active CN102154405B (en) 2011-01-13 2011-01-13 Preparation method of hyaluronic acid

Country Status (1)

Country Link
CN (1) CN102154405B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105861596A (en) * 2015-01-23 2016-08-17 中国科学院微生物研究所 Method for preparing hyaluronic acid
CN106381279A (en) * 2016-08-29 2017-02-08 中国药科大学 Extracellular polymeric substances, preparation method and application thereof
CN110045045A (en) * 2019-05-28 2019-07-23 中山市天然保贸易有限公司 The detection method of hyaluronic acid contents in a kind of facial mask
CN112522125A (en) * 2020-12-28 2021-03-19 河北省微生物研究所 Hyaluronidase engineering bacterium and construction method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101633931A (en) * 2008-07-25 2010-01-27 山东省生物药物研究院 Hyaluronidase expression vector and application thereof
CN101643760A (en) * 2009-09-04 2010-02-10 四川理工学院 Method for increasing the yield of hyaluronic acid

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101633931A (en) * 2008-07-25 2010-01-27 山东省生物药物研究院 Hyaluronidase expression vector and application thereof
CN101643760A (en) * 2009-09-04 2010-02-10 四川理工学院 Method for increasing the yield of hyaluronic acid

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
HUIMIN YU等: "A High-Throughput Screen for Hyaluronic Acid Accumulation in Recombinant Escherichia coli Transformed by Libraries of Engineered Sigma Factors", 《BIOTECHNOLOGY AND BIOENGINEERING》, vol. 101, no. 4, 1 November 2008 (2008-11-01) *
HUIMIN YU等: "Metabolic engineering of Escherichia coli for biosynthesis of hyaluronic acid", 《METABOLIC ENGINEERING》, vol. 10, 31 December 2008 (2008-12-31) *
刘飞等: "兽疫链球菌透明质酸酶在大肠杆菌中的高效表达和酶学性质", 《山东生物化学与分子生物学会2009年学术会议论文汇编》, 31 December 2009 (2009-12-31) *
易梅等: "透明质酸的应用及制备方法", 《中国生物工程杂志》, vol. 28, no. 6, 31 December 2008 (2008-12-31) *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105861596A (en) * 2015-01-23 2016-08-17 中国科学院微生物研究所 Method for preparing hyaluronic acid
CN105861596B (en) * 2015-01-23 2020-02-04 中国科学院微生物研究所 Preparation method of hyaluronic acid
CN106381279A (en) * 2016-08-29 2017-02-08 中国药科大学 Extracellular polymeric substances, preparation method and application thereof
CN106381279B (en) * 2016-08-29 2019-11-05 中国药科大学 A kind of extracellular polysaccharide of bacteria, preparation method and its application
CN110045045A (en) * 2019-05-28 2019-07-23 中山市天然保贸易有限公司 The detection method of hyaluronic acid contents in a kind of facial mask
CN110045045B (en) * 2019-05-28 2021-08-06 中山市天然保贸易有限公司 Method for detecting content of hyaluronic acid in facial mask
CN112522125A (en) * 2020-12-28 2021-03-19 河北省微生物研究所 Hyaluronidase engineering bacterium and construction method and application thereof

Also Published As

Publication number Publication date
CN102154405B (en) 2013-03-20

Similar Documents

Publication Publication Date Title
CN105055440B (en) Purposes of oligomerization hyaluronic acid or oligomerization hyaluronate and combinations thereof
ES2396955T3 (en) Procedure for the purification of high molecular weight hyaluronic acid
CN1322121C (en) Hyaluronan synthase gene and uses thereof
Coste et al. Production of sulfated oligosaccharides from the seaweed Ulva sp. using a new ulvan-degrading enzymatic bacterial crude extract
CN101608166B (en) Flavobacterium strain and application thereof in generating agarase
CN105431534A (en) beta-1,3-glucanase, polynucleotide, recombinant vector, transformant, production method for beta-1,3-glucanase, enzyme preparation, and production method for paramylon having reduced molecular weight
CN102154405B (en) Preparation method of hyaluronic acid
da Silva et al. Xanthan: biotechnological production and applications
CN102112617A (en) Process for co-production of chitin, its derivatives and polymers containing glucose, mannose and/or galactose, by fermentation of yeast pichia pastoris
CN110923173A (en) Enterobacter and application thereof
CN102154190B (en) Engineering escherichia coli capable of efficiently producing hyaluronic acid and preparation method thereof
CN108410783B (en) Method for producing glucosamine by culturing escherichia coli and fermenting
CN109988731A (en) One plant of welan gum superior strain Sphingol single-cell TJA 3-1 and its methods and applications for producing welan gum
CN106367459A (en) Method for preparing oligomeric hyaluronic acid with different molecular weights
CN106434475B (en) One streptomycete category polysaccharide degradation bacteria and its cultural method and application
Wang et al. Structural characterization and bioactivity of exopolysaccharide synthesized by Geobacillus sp. TS3-9 isolated from radioactive radon hot spring
JP5969390B2 (en) Fucose-containing bacterial biopolymer
US20080064073A1 (en) Process for Preparing
CN102154360B (en) Recombinant expression vectors pQHK and pHK producing hyaluronic acid and construction method thereof
CN112458022B (en) Bacillus licheniformis Bl22 for high yield of chitin deacetylase and related products and application thereof
CN104498412B (en) Cohnella sp. capable of degrading agar
CN105567606A (en) Arthrobacter globiformis and hyaluronidase generated by arthrobacter globiformis
CN101113436B (en) Hyaluronan synthase gene and uses thereof
CN113322207B (en) Microbacterium XL1 and application thereof in Levan fructan production
Kazak Exopolysaccharide production by Halomonas strains isolated from Turkey

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: A preparation method of hyaluronic acid

Effective date of registration: 20231120

Granted publication date: 20130320

Pledgee: Kunming Dongfeng Sub branch of Bank of China Ltd.

Pledgor: MICROBIAL FERMENTATION ENGINEERING RESEARCH CENTER Co.,Ltd. OF YUNNAN PROVINCE

Registration number: Y2023530000066

PE01 Entry into force of the registration of the contract for pledge of patent right